Anne Etienne
Gap, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Early preemptive ICU admission for newly diagnosed high-risk acute myeloid leukemia patients.
Journal: Leukemia research
Published: January 26, 2018
Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study.
Journal: Haematologica
Published: January 02, 2015
Comparison of 60 or 90 mg/m(2) of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics.
Journal: American journal of hematology
Published: October 24, 2014
Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients.
Journal: American journal of hematology
Published: September 09, 2014
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: May 05, 2014
Evaluation of comorbidity indexes in the outcome of elderly patients treated for acute lymphoblastic leukemia.
Journal: Leukemia & lymphoma
Published: December 21, 2013
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
Journal: American journal of hematology
Published: May 27, 2013
Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique.
Journal: British journal of haematology
Published: February 19, 2013
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: October 23, 2012
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission.
Journal: Blood
Published: September 25, 2012
Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline induction.
Journal: Leukemia & lymphoma
Published: May 16, 2012
Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 03, 2012
Last Updated: 09/26/2026